Part of the Pharmaceutics and Drug Design Commons

Works by Sarah A. Nisly in Pharmaceutics and Drug Design

2015

Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Alison M. Walton

PDF

2014

Use of a Subcutaneous Insulin Computerized GlucoStabilizer™ Program on Glycemic Control in the Intensive Care Setting: A Retrospective Data Analysis., Sarah A. Nisly, Serena Harris, Laura Aykroyd, Joni Carrol, Brian Ulmer, Michael Waddell, Samuel Flanders, Rattan Juneja
Sarah A. Nisly

PDF

Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Sarah A. Nisly

PDF

2013

Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton
Scholarship and Professional Work – COPHS

PDF

Use of a Subcutaneous Insulin Computerized GlucoStabilizer™ Program on Glycemic Control in the Intensive Care Setting: A Retrospective Data Analysis., Sarah A. Nisly, Serena Harris, Laura Aykroyd, Joni Carrol, Brian Ulmer, Michael Waddell, Samuel Flanders, Rattan Juneja
Scholarship and Professional Work – COPHS

PDF